Barrowcliffe Susan E.
Related Filers (1)
Ownership (13)
4
Wednesday, 11/21/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/6/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/27/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/7/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/31/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/6/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/24/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/15/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/10/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/26/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 1/22/2016
Aimmune Therapeutics, Inc.: Initial statement of beneficial ownership of securities